Premium
Feasibility of endoscopic submandibular ganglion neurectomy for drooling
Author(s) -
Ozturk Kayhan,
Erdur Omer,
Gul Osman,
Olmez Ayse
Publication year - 2017
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1002/lary.26557
Subject(s) - drooling , neurectomy , medicine , ganglion , sialorrhea , surgery , anatomy , pathology , alternative medicine
We performed endoscopic transoral neurectomy of the submandibular and sublingual glands to treat drooling. We bilaterally operated two adult cases with treatment‐resistant drooling. In these patients, conventional treatment had failed. Repeated botilinum toxin type A (BOTOX®, Abdi Ibrahim Pharmaceutical Company, Istanbul, Turkey) injections had been effective but were becoming less so. The patients benefited from surgery in that their saliva scores decreased. No issue emerged over 6 months of follow‐up. Endoscopic transoral neurectomy of the submandibular and sublingual glands reduces saliva production and allows management of drooling in treatment‐resistant patients. Laryngoscope , 127:1604–1607, 2017